EUVIMEDEUVIMED entdecken
Crossref

m 6 A‐induced TRIB3 regulates Hippo pathway through interacting with LATS1 to promote the progression of lung adenocarcinoma

Jiamei Wu, Tingzhuang Yi, Chenyi Zhuo, Duanduan Wang, Ming Zhang, Rui Hu, Dan Wu, Guoxin Hou, Yutong Xing iD

Journal of Cellular Physiology · 2024

DOI: 10.1002/jcp.31220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2024. Verfasst von Jiamei Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Science, Baicheng Medical College, Baicheng, Jilin, P. R. China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Cell Cycle Proteins, Cell Proliferation, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Clinical Key Specialty Construction Project-Oncology department, Key Discipline Established by Zhejiang Province and Jiaxing City Joint-Oncology Medicine, Jilin Provincial Natural Science Foundation General Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies have indicated that dysregulation of the Hippo/Yes‐associated protein (YAP) axis is associated with tumor progression and therapy resistance in various cancer types, including lung adenocarcinoma (LUAD). Understanding the regulation of Hippo signaling in LUAD is of great significance. Elevated levels of TRIB3, a pseudo kinase, have been observed in certain lung malignancies and are associated with an unfavorable prognosis. Our research aims to investigate whether increased TRIB3 levels enhance the malignant characteristics of LUAD cells and tumor progression through its interaction with the Hippo signaling pathway. In this study, we reported a positive correlation between elevated expression of TRIB3 and LUAD progression. Additionally, TRIB3 has the ability to enhance TEAD luciferase function and suppress Hippo pathway activity. Moreover, TRIB3 increases total YAP protein levels and promotes YAP nuclear localization. Mechanistic experiments revealed that TRIB3 directly interacts with large tumor suppressor kinase 1 (LATS1), thereby suppressing Hippo signaling. Moreover, the decrease in METTL3‐mediated N6‐methyladenosine modification of TRIB3 results in a substantial elevation of its expression levels in LUAD cells. Collectively, our research unveils a novel discovery that TRIB3 enhances the growth and invasion of LUAD cells by interacting with LATS1 and inhibiting the Hippo signaling pathway. TRIB3 may serve as a potential biomarker for an unfavorable prognosis and a target for novel treatments in YAP‐driven lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungCell Cycle ProteinsCell ProliferationGene Expression Regulation, NeoplasticHippo Signaling PathwayLung NeoplasmsProtein Serine-Threonine KinasesRepressor ProteinsAnimalsFemaleHumansMaleA549 CellsAdaptor Proteins, Signal TransducingAdenosineCell Line, TumorCell MovementDisease ProgressionMethyltransferasesSignal TransductionTranscription FactorsYAP-Signaling Proteins

Stichwörter der Autor:innen

HippoLATS1METTL3TRIB3YAP

Substanzen

Adaptor Proteins, Signal TransducingAdenosineCell Cycle ProteinsMethyltransferasesProtein Serine-Threonine KinasesTranscription FactorsYAP-Signaling ProteinsTRIB3 protein, humanLATS1 protein, humanRepressor Proteins

Autor:innen und Institutionen

  • Department of Basic Medical Science, Baicheng Medical College, Baicheng, Jilin, P. R. China.
  • Department of Oncology, Affiliated Hospital of YouJiang Medical University for Nationalities, Baise, Guangxi, P. R. China.
  • Guangxi Clinical Medical Research Center for Hepatobiliary Diseases, Baise, Guangxi, P. R. China.
  • Department of Cardiothoracic Surgery, The Fifth Hospital of Xiamen, Xiamen, China.
  • Department of Oncology, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China.

ORCID-Profile: Yutong Xing

Förderung

  • National Clinical Key Specialty Construction Project-Oncology department
  • Key Discipline Established by Zhejiang Province and Jiaxing City Joint-Oncology Medicine
  • Jilin Provincial Natural Science Foundation General Project
  • Xiamen Medical and Health Guiding Projects

Zitieren

APA

Wu, J., Yi, T., Zhuo, C., Wang, D., Zhang, M., Hu, R., Wu, D., Hou, G., & Xing, Y. (2024). m 6 A‐induced TRIB3 regulates Hippo pathway through interacting with LATS1 to promote the progression of lung adenocarcinoma. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31220

Vancouver

Wu J, Yi T, Zhuo C, Wang D, Zhang M, Hu R, et al. m 6 A‐induced TRIB3 regulates Hippo pathway through interacting with LATS1 to promote the progression of lung adenocarcinoma. Journal of Cellular Physiology. 2024. doi:10.1002/jcp.31220

BibTeX
@article{Wu2024,
  author = {Wu, Jiamei and Yi, Tingzhuang and Zhuo, Chenyi and Wang, Duanduan and Zhang, Ming and Hu, Rui and Wu, Dan and Hou, Guoxin and Xing, Yutong},
  title = {m 6 A‐induced TRIB3 regulates Hippo pathway through interacting with LATS1 to promote the progression of lung adenocarcinoma},
  journal = {Journal of Cellular Physiology},
  year = {2024},
  doi = {10.1002/jcp.31220}
}
Kostenlos starten →